Diffuse Bio | LinkedIn (original) (raw)
About us
We build generative AI for protein therapeutics.
Industry
Biotechnology Research
Company size
2-10 employees
Type
Privately Held
Employees at Diffuse Bio
Updates
- Diffuse Bio reposted this
Investor at GreatPoint Ventures
5mo
Tremendous progress by the Diffuse Bio team building at the intersection of generative AI and protein design. A seven orders of magnitude improvement in hit rate (i.e., binding to the target of interest) than industry-standard discovery approaches. And it’s just the beginning…
Founder @ Diffuse Bio -- we're hiring!
5mo
I’m excited to share some of our progress at Diffuse Bio today, about a year and a half into our journey! At Diffuse, we’re building generative AI for protein design. Our mission is to build AI that engineers new and useful proteins with unprecedented control and accuracy. Today we introduce Diffuse StructGen-1 (DSG-1), a new foundation model for protein design. We prompted DSG-1 to design nanobody binders, a therapeutically relevant class of proteins. Remarkably, DSG-1 designs bound the target with a 3% hit rate, about seven orders of magnitude better than industry-standard discovery approaches. Importantly, we are able to design strong binders (<=10nM range) – a significant advance over previous work. More details can be found in our blog post linked below! We are in the early stages of AI development in molecular design, and we envision a future where AI enables rapid and accurate design of any protein. If our mission resonates with you please reach out at hello@diffuse.bio.
Diffuse Bio diffuse.bio - Diffuse Bio reposted this
Protein design often feels like shooting darts while blindfolded in the dark, so getting to Diffuse Bio's hit rate in 2 years time is incredible!
Founder @ Diffuse Bio -- we're hiring!
5mo
I’m excited to share some of our progress at Diffuse Bio today, about a year and a half into our journey! At Diffuse, we’re building generative AI for protein design. Our mission is to build AI that engineers new and useful proteins with unprecedented control and accuracy. Today we introduce Diffuse StructGen-1 (DSG-1), a new foundation model for protein design. We prompted DSG-1 to design nanobody binders, a therapeutically relevant class of proteins. Remarkably, DSG-1 designs bound the target with a 3% hit rate, about seven orders of magnitude better than industry-standard discovery approaches. Importantly, we are able to design strong binders (<=10nM range) – a significant advance over previous work. More details can be found in our blog post linked below! We are in the early stages of AI development in molecular design, and we envision a future where AI enables rapid and accurate design of any protein. If our mission resonates with you please reach out at hello@diffuse.bio.
Diffuse Bio diffuse.bio - Diffuse Bio reposted this
Founder @ Diffuse Bio -- we're hiring!
5mo
I’m excited to share some of our progress at Diffuse Bio today, about a year and a half into our journey! At Diffuse, we’re building generative AI for protein design. Our mission is to build AI that engineers new and useful proteins with unprecedented control and accuracy. Today we introduce Diffuse StructGen-1 (DSG-1), a new foundation model for protein design. We prompted DSG-1 to design nanobody binders, a therapeutically relevant class of proteins. Remarkably, DSG-1 designs bound the target with a 3% hit rate, about seven orders of magnitude better than industry-standard discovery approaches. Importantly, we are able to design strong binders (<=10nM range) – a significant advance over previous work. More details can be found in our blog post linked below! We are in the early stages of AI development in molecular design, and we envision a future where AI enables rapid and accurate design of any protein. If our mission resonates with you please reach out at hello@diffuse.bio.
Diffuse Bio diffuse.bio - Diffuse Bio reposted this
General Partner at Humba Ventures and Susa Ventures
5mo
Pretty insane results from Diffuse Bio for applying generative AI to protein design. 7 order-of-magnitude improvement vs. the status quo! https://lnkd.in/e86HgDDT - Diffuse Bio reposted this
Group Partner at Y Combinator | Author of Without a Doubt | Founder of nVision (now part of NYSE: BSX) | Board Director | Grape Grower
5mo
I could not be more excited about these results, about Namrata A. as a founder, and what this means for the future of research and discovery.
Founder @ Diffuse Bio -- we're hiring!
5mo
I’m excited to share some of our progress at Diffuse Bio today, about a year and a half into our journey! At Diffuse, we’re building generative AI for protein design. Our mission is to build AI that engineers new and useful proteins with unprecedented control and accuracy. Today we introduce Diffuse StructGen-1 (DSG-1), a new foundation model for protein design. We prompted DSG-1 to design nanobody binders, a therapeutically relevant class of proteins. Remarkably, DSG-1 designs bound the target with a 3% hit rate, about seven orders of magnitude better than industry-standard discovery approaches. Importantly, we are able to design strong binders (<=10nM range) – a significant advance over previous work. More details can be found in our blog post linked below! We are in the early stages of AI development in molecular design, and we envision a future where AI enables rapid and accurate design of any protein. If our mission resonates with you please reach out at hello@diffuse.bio.
Diffuse Bio diffuse.bio - We’re Diffuse Bio, and we build generative AI to design functional proteins that people need. We’re developing 🤖 foundation and generative machine learning models for proteins, as well as 🧬 radically new assays to gather biological data at scale. We are an interdisciplinary team of experimentalists, MLREs, and SWEs. Join us or get in touch: https://diffuse.bio